Back
Dermata Therapeutics, Inc. Vs. AXT, Inc. Industry Stock Comparison
Sell
40
DRMA
Dermata Therapeutics, Inc.
Last Price:
$1.28
Seasonality Move:
-37.41%
Sell
42
AXTI
AXT, Inc.
Last Price:
$52.95
Seasonality Move:
9.66%
Sell
40
Dermata Therapeutics, Inc. (DRMA)
is a Sell
Is Dermata Therapeutics, Inc. a Buy, Sell or Hold?
-
The current Dermata Therapeutics, Inc. [DRMA] share price is $1.29. The Score for DRMA is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
-
DRMA is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
42
AXT, Inc. (AXTI)
is a Sell
Is AXT, Inc. a Buy, Sell or Hold?
-
AXTI is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
DRMA Stock Price Chart
What is Dermata Therapeutics, Inc.'s stock price today?
-
The Dermata Therapeutics, Inc. share price today is $1.29Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and DRMA is experiencing buying pressure, which is a positive indicator for future bullish movement.
AXTI Stock Price Chart
DRMA Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.06 | Sell |
| Relative Strength Index (14 RSI): | 47.45 | Sell |
| Chaikin Money Flow: | 128481 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.15 - 1.39) | Buy |
| Bollinger Bands (100): | (1.38 - 2.7) | Sell |
AXTI Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 5.28 | Buy |
| Relative Strength Index (14 RSI): | 53.39 | Buy |
| Chaikin Money Flow: | 15364772 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (40.44 - 59.16) | Buy |
| Bollinger Bands (100): | (10.03 - 41.59) | Buy |
DRMA Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.3 | Sell |
| 20-day SMA: | 1.29 | Sell |
| 50-day SMA: | 1.54 | Sell |
| 200-day SMA: | 3.8 | Sell |
| 8-day EMA: | 1.27 | Buy |
| 20-day EMA: | 1.31 | Sell |
| 50-day EMA: | 1.56 | Sell |
| 200-day EMA: | 5.5 | Sell |
AXTI Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 58.08 | Sell |
| 20-day SMA: | 52.05 | Buy |
| 50-day SMA: | 36.82 | Buy |
| 200-day SMA: | 14.71 | Buy |
| 8-day EMA: | 54.71 | Sell |
| 20-day EMA: | 51.49 | Buy |
| 50-day EMA: | 40.68 | Buy |
| 200-day EMA: | 20.19 | Buy |
Dermata Therapeutics, Inc. Earnings Growth & DRMA Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
AXT, Inc. Earnings Growth & AXTI Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.14 per share, an increase next quarter of $0.05 per share, an increase this year of $0.42 per share, and an increase next year of $0.46 per share.
Dermata Therapeutics, Inc. Technical Analysis
| Mar 20 | Mar 23 | Mar 24 | Mar 25 | Mar 26 | Mar 27 | Mar 30 | Mar 31 | Apr 1 | Apr 2 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | Apr | |||||||||
| 20 | 23 | 24 | 25 | 26 | 27 | 30 | 31 | 01 | 02 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
AXT, Inc. Technical Analysis
| Mar 20 | Mar 23 | Mar 24 | Mar 25 | Mar 26 | Mar 27 | Mar 30 | Mar 31 | Apr 1 | Apr 2 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | Apr | |||||||||
| 20 | 23 | 24 | 25 | 26 | 27 | 30 | 31 | 01 | 02 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||